ACI Formulations (DHA:ACIFORMULA) Long-Term Capital Lease Obligation : BDT25 Mil (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is ACI Formulations Long-Term Capital Lease Obligation?

ACI Formulations's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was BDT25 Mil.

ACI Formulations's quarterly Long-Term Capital Lease Obligation declined from Jun. 2023 (BDT31 Mil) to Sep. 2023 (BDT28 Mil) and declined from Sep. 2023 (BDT28 Mil) to Dec. 2023 (BDT25 Mil).

ACI Formulations's annual Long-Term Capital Lease Obligation increased from Jun. 2021 (BDT7 Mil) to Jun. 2022 (BDT8 Mil) and increased from Jun. 2022 (BDT8 Mil) to Jun. 2023 (BDT31 Mil).

ACI Formulations Long-Term Capital Lease Obligation Historical Data

The historical data trend for ACI Formulations's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACI Formulations Long-Term Capital Lease Obligation Chart

ACI Formulations Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

11.00

4.39

7.34

8.31

31.28

ACI Formulations Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															26.44	24.61	31.28	28.36	25.26

ACI Formulations (DHA:ACIFORMULA) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

ACI Formulations Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of ACI Formulations's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

ACI Formulations (DHA:ACIFORMULA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » ACI Formulations Ltd (DHA:ACIFORMULA) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

ACI Centre, 245, Tejgaon Industrial Area, Dhaka, BGD, 1208

Website

https://www.aci-bd.com

ACI Formulations Ltd is an agricultural chemicals manufacturer. The principal activities of the company are manufacturing and marketing a number of agrochemical and consumer products. The company has structured its operations into the following business segments - Crop Care and Public Health segment, which manufactures and sell crop care and public health products; Mosquito Coil segment is engaged in the manufacturing and selling of mosquito coil products; the Aerosol segment is engaged in the manufacturing and selling aerosol and air freshener products; and Paint segment which manufactures and sells paint products. It derives key revenue from the Crop Care and Public Health segment.

ACI Formulations (DHA:ACIFORMULA) Headlines

No Headlines